Long T. Zheng
Jiangsu Key Laboratory Of Neuropsychiatric Diseases And College Of Pharmaceutical Sciences
Suzhou, China
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Kinase signaling networks governing neuroinflammatory glial phenotypes: Current understanding and emerging targets.
Journal: Histology and histopathology
Published: June 11, 2026
Transcriptomic and functional annotation datasets for GV1001 peptide treatment in an experimental autoimmune encephalomyelitis mouse model.
Journal: Data in brief
Published: November 01, 2025
Therapeutic effects of telomerase-derived peptide GV1001 in experimental autoimmune encephalomyelitis: Inhibiting neuroinflammation and promoting remyelination.
Journal: Biochemical pharmacology
Published: August 08, 2025
Knockdown of milk-fat globule EGF factor-8 suppresses glioma progression in GL261 glioma cells by repressing microglial M2 polarization.
Journal: Journal of cellular physiology
Published: December 29, 2019
Clk1-regulated aerobic glycolysis is involved in glioma chemoresistance.
Journal: Journal of neurochemistry
Published: December 15, 2016
Accessible Method for the Development of Novel Sterol Analogues with Dipeptide-like Side Chains That Act as Neuroinflammation Inhibitors.
Journal: ACS chemical neuroscience
Published: January 28, 2016
Antiinflammatory effects of orientin-2"-O-galactopyranoside on lipopolysaccharide-stimulated microglia.
Journal: Biological & pharmaceutical bulletin
Published: August 05, 2014
1-O-tigloyl-1-O-deacetyl-nimbolinin B inhibits LPS-stimulated inflammatory responses by suppressing NF-κB and JNK activation in microglia cells.
Journal: Journal of pharmacological sciences
Published: July 15, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026